Eagle Genomics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 94
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $8.88M
Latest Deal Amount
  • Investors
  • 19

Eagle Genomics General Information

Description

Developer of a knowledge discovery platform designed to conduct data-intensive research in life sciences. The company's platform provides an easy to use intuitive approach for curating, integrating, sharing, analyzing and valuing scientific data for clinical and molecular studies in life sciences and fields where similar challenges have been addressed, enabling clients to deliver products and technologies into their respective markets.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Database Software
Other Industries
Biotechnology
Other Healthcare Technology Systems
Primary Office
  • 90 York Way
  • London N1 9AG
  • England, United Kingdom
+44 01223 000000

Eagle Genomics Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eagle Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series A) 26-Oct-2020 $8.88M 0000 000.00 Completed Generating Revenue
11. Accelerator/Incubator 12-Nov-2019 00.000 Completed Generating Revenue
10. Accelerator/Incubator 30-Jul-2019 00.000 Completed Generating Revenue
9. Later Stage VC 04-Feb-2019 00.000 00.000 000.00 Completed Generating Revenue
8. Later Stage VC 20-Jun-2018 00.000 00.000 00.000 Completed Generating Revenue
7. Accelerator/Incubator 09-Mar-2018 00.000 Completed Generating Revenue
6. Grant 09-Feb-2018 00.000 00.000 Completed Generating Revenue
5. Grant 01-Aug-2017 00000 00.000 Completed Generating Revenue
4. Later Stage VC 25-Nov-2016 $1.28M $3.51M 000 Completed Generating Revenue
3. Later Stage VC 24-Aug-2015 $624K $2.23M 00.000 Completed Generating Revenue
To view Eagle Genomics’s complete valuation and funding history, request access »

Eagle Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000 00.000000 0000.00 0000.00 0000.00 00.000
Series B 00,000 00.000000 0000.00 0000.00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 0000.00 0.000
Ordinary 00 00.000000 00000.00 00000.00 00000.00 0.000
Series A 000 00.000000 000.00 000.00 000.00 0.000
Series A 00,000 00.000000 0000.00 0000.00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 0000.00 0.000
Ordinary 000 00.000000 000.00 000.00 000.00 0.000
Ordinary 17,166 $0.012951 $77.71 $77.71 $77.71 10.21%
Ordinary 8,689 $0.012951 $59.63 $59.63 $59.63 5.17%
To view Eagle Genomics’s complete cap table history, request access »

Eagle Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a knowledge discovery platform designed to conduct data-intensive research in life sciences. The company's
Database Software
London, United Kingdom
94 As of 2021
0000
00.00 0000-00-00
00000000000 0000

0000000

incididunt ut labore et dolore magna a
00000 0000000000 0000000000 0000000
Lund, Sweden
00 As of 0000
000.00
00.00 0000-00-00
00000000 000.00

00000000

t dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut al
00000 0000000000 00000000
New York, NY
00 As of 0000
00.00
0000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eagle Genomics Competitors (32)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Qlucore Formerly VC-backed Lund, Sweden 00 000.00 00000000 000.00
00000000 Venture Capital-Backed New York, NY 00 00.00 0000000000 00.00
0000000000 0000 00 Accelerator/Incubator Backed Foster City, CA 000 00.000 000000000 - 00.000
00000000 Venture Capital-Backed Mountain View, CA 000 00000 00000000000 00000
000000 00000000 Formerly VC-backed Saint Sulpice, Switzerland 000 00000 000000000 00000
You’re viewing 5 of 32 competitors. Get the full list »

Eagle Genomics Executive Team (11)

Name Title Board Seat Contact Info
Anthony Finbow Chief Executive Officer & Board Member
Gavin Horn Chief Financial Officer
Radouane Oudrhiri Chief Technology Officer
You’re viewing 3 of 11 executive team members. Get the full list »

Eagle Genomics Board Members (11)

Name Representing Role Since
Anthony Finbow Eagle Genomics Chief Executive Officer & Board Member 000 0000
Clifford Meltzer Self Non-Executive Chairman 000 0000
Delphine Gény-Stephann Eagle Genomics Board Member 000 0000
Miklós Kóbor Self Board Member 000 0000
Robert Genieser ETF Partners Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Eagle Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eagle Genomics Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Albert-László Barabási Angel (individual) Minority 000 0000 000000 0
Anatom Holding Other Minority 000 0000 000000 0
bpd partners Family Office Minority 000 0000 000000 0
Granpool PE/Buyout Minority 000 0000 000000 0
EIT Food Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »